191658-29-4

Upstream product

• 67-56-1 methanol 
• 103-16-2 4-Benzyloxyphenol 
• 41841-16-1 (4-bromo-phenyl)-acetic acid methyl ester 
• 500-79-8 [4-(4-hydroxyphenoxy)phenyl]acetic acid 
• 100-39-0 benzyl bromide 
• 403-42-9 1-(4-fluorophenyl)ethanone 
• 257609-02-2 1-(4-(4-(benzyloxy)phenoxy)phenyl)ethan-1-one 
• 257609-05-5 2-(4-(4-benzyloxyphenoxy)phenyl)-1-morpholin-4-yl-ethanethione 

Downstream Products

• 257609-42-0 2-(2-(4-(4-Benzyloxyphenoxy)phenyl)acetylamino)benzoic acid methyl ester 
• 852631-22-2 5-[4-(4-benzyloxyphenoxy)phenyl]pyrimidine-2,4,6-trione 
• 852631-18-6 [4-(4-benzyloxyphenoxy)phenyl]malonic acid dimethyl ester 
• 852631-14-2 [4-(4-benzyloxyphenoxy)phenyl]acetic acid methyl ester 

Relevant academic research and scientific papers

C-5-disubstituted barbiturates as potential molecular probes for noninvasive matrix metalloproteinase imaging

Studies have demonstrated a positive correlation between inflammation, metastasis, or atherosclerosis and the unbalanced or culminated expression of matrix metalloproteinases (MMPs). The molecular imaging of locally upregulated MMP activity in vivo is a c

Cancer remedy comprising anthranilic acid derivatives as active ingredients

A cancer remedy comprising a compound represented by the following formula as an active ingredient: wherein, X represents a group represented by either of the following formulae: wherein, R1 and R2 represent each a hydrogen atom, a h

Anthranilic acid derivatives

The present invention relates to an anthranilic acid derivative expressed by the following formula (1) or the following formula (2), or its pharmacologically permissible salt or solvate.

Benzene derivatives

Novel benzene derivatives of the formula (I) shown below, pharmacological salts thereof, pharmacological solvates of the above-mentioned benzene derivatives and salts, pharmaceutical compositions including, as active ingredients, the above-mentioned compo